Atossa Genetics Announces Chimeric Antigen Receptor Therapy … – GlobeNewswire (press release)
|
Atossa Genetics Announces Chimeric Antigen Receptor Therapy …
GlobeNewswire (press release) SEATTLE, Oct. 02, 2017 (GLOBE NEWSWIRE) — Atossa Genetics (NASDAQ:ATOS), a clinical-stage pharmaceutical company developing novel therapeutics … |
